Title: Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120701
Title: Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.
Journal: Cell communication and signaling : CCS 20110101
Title: Intracellular trafficking as a determinant of AS-DACA cytotoxicity in rhabdomyosarcoma cells.
Journal: BMC cell biology 20110101
Title: Attenuation of cytotoxic natural product DNA intercalating agents by caffeine.
Journal: Scientia pharmaceutica 20110101
Title: In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20100801
Title: In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Journal: Cancer chemotherapy and pharmacology 20091101
Title: Early tumor drug pharmacokinetics is influenced by tumor perfusion but not plasma drug exposure.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081215
Title: The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049.
Journal: Cancer chemotherapy and pharmacology 20081001
Title: Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Journal: Bioorganic & medicinal chemistry 20080815
Title: Plasma pharmacokinetic evaluation of cytotoxic agents radiolabelled with positron emitting radioisotopes.
Journal: Cancer chemotherapy and pharmacology 20080401
Title: Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: a molecular modelling study.
Journal: Clinical and experimental pharmacology & physiology 20050801
Title: Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?
Journal: Current medicinal chemistry 20031201
Title: Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
Journal: Journal of medicinal chemistry 20030313
Title: Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030115
Title: Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography.
Journal: Current pharmaceutical design 20030101
Title: Inter-strain variability in aldehyde oxidase activity in the mouse.
Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20020701
Title: Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.
Journal: Journal of medicinal chemistry 20020214
Title: Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Journal: Anti-cancer drug design 20011201
Title: Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.
Journal: British journal of clinical pharmacology 20010801
Title: Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): diffusion and metabolism in multicellular layers of tumor cells.
Journal: The Journal of pharmacology and experimental therapeutics 20010601
Title: Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Journal: Cancer research 20010401
Title: Individual variation in hepatic aldehyde oxidase activity.
Journal: IUBMB life 20010401
Title: Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301
Title: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs.
Journal: Cancer chemotherapy and pharmacology 20000101
